Meridian Bioscience Inc (VIVO)

19.24
NASDAQ : Health Care
Prev Close 19.25
Day Low/High 18.88 / 19.46
52 Wk Low/High 16.60 / 21.49
Avg Volume 216.10K
Exchange NASDAQ
Shares Outstanding 42.09M
Market Cap 810.17M
EPS 0.80
P/E Ratio 22.92
Div & Yield 0.80 (4.20%)

Latest News

10.8% of DGRS Holdings Seeing Recent Insider Buys

10.8% of DGRS Holdings Seeing Recent Insider Buys

A look at the weighted underlying holdings of the WisdomTree US SmallCap Quality Dividend Growth Fund (DGRS) shows an impressive 10.8% of holdings on a weighted basis have experienced insider buying within the past six months. START SLIDESHOW:10 ETFs With Stocks That Insiders Are Buying » Meridian Bioscience Inc.

VIVO: Insiders vs. Shorts

VIVO: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/29/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 18.18 "days to cover" versus the median component at 6.42.

Magellan Diagnostics Receives CFDA Clearance For LeadCare II In China

Magellan Diagnostics Receives CFDA Clearance For LeadCare II In China

Simple, portable diagnostic instrument used in thousands of US clinics will provide three-minute blood lead testing results to Chinese clinicians and parents.

Magellan Diagnostics Receives CFDA Clearance For LeadCare® II In China

Magellan Diagnostics Receives CFDA Clearance For LeadCare® II In China

Simple, portable diagnostic instrument used in thousands of US clinics will provide three-minute blood lead testing results to Chinese clinicians and parents

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

In trading on Friday, shares of Meridian Bioscience Inc. crossed below their 200 day moving average of $19.63, changing hands as low as $19.19 per share.

VIVO Crosses Above Average Analyst Target

VIVO Crosses Above Average Analyst Target

In recent trading, shares of Meridian Bioscience Inc. have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.13/share.

VIVO: Insiders vs. Shorts

VIVO: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 24.46 "days to cover" versus the median component at 6.60.

Meridian Bioscience Launches New Molecular Test For The Detection Of Mycoplasma Pneumoniae

Meridian Bioscience Launches New Molecular Test For The Detection Of Mycoplasma Pneumoniae

illumigene® Mycoplasma Direct provides fast and accurate results in less than 1 hour for immediate and targeted treatment

VIVO Breaks Above 4% Yield Territory

VIVO Breaks Above 4% Yield Territory

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Meridian Bioscience Inc. were yielding above the 4% mark based on its quarterly dividend (annualized to $0.80), with the stock changing hands as low as $19.96 on the day.

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

Meridian Bioscience Breaks Below 200-Day Moving Average - Notable for VIVO

In trading on Tuesday, shares of Meridian Bioscience Inc. crossed below their 200 day moving average of $18.65, changing hands as low as $18.48 per share.

Ex-Dividend Reminder: Meridian Bioscience, New York REIT and Capital Bank Financial

Ex-Dividend Reminder: Meridian Bioscience, New York REIT and Capital Bank Financial

Looking at the universe of stocks we cover at Dividend Channel, on 2/4/16, Meridian Bioscience Inc. , New York REIT Inc , and Capital Bank Financial Corp will all trade ex-dividend for their respective upcoming dividends.

New Malaria Test, Illumigene® Malaria, Sets A New Gold Standard For Diagnosis

New Malaria Test, Illumigene® Malaria, Sets A New Gold Standard For Diagnosis

Meridian Bioscience Collaborates With the Centers for Disease Control and Prevention and Cheikh Anta Diop University of Dakar to Launch Diagnostic Test up to 80,000 Times More Sensitive Than Current Options

3 Undiscovered, Undervalued Health Care Stocks Poised to Outperform the Sector in 2016

3 Undiscovered, Undervalued Health Care Stocks Poised to Outperform the Sector in 2016

Investors already know that the multitrillion-dollar health care sector is booming, but these exceptional growth plays in health are largely ignored, which is a great opportunity now for you.

Bioline Launches New JetSeq™ DNA Library Preparation Kit

Bioline Launches New JetSeq™ DNA Library Preparation Kit

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc.

Insider Trading Alert - VIVO, CCG And PDCE Traded By Insiders

Insider Trading Alert - VIVO, CCG And PDCE Traded By Insiders

Stocks with insider trader activity include VIVO, CCG and PDCE

Meridian Receives FDA Clearance For New Molecular Whooping Cough Test Claims

Meridian Receives FDA Clearance For New Molecular Whooping Cough Test Claims

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced it has received clearance from the U.

Meridian Bioscience Announces Investment In Oasis Diagnostics®

Meridian Bioscience Announces Investment In Oasis Diagnostics®

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has made a minority investment in Oasis Diagnostics ® Corporation ("Oasis"), with the right to acquire Oasis in the future.

VIVO Dividend Yield Pushes Above 4%

VIVO Dividend Yield Pushes Above 4%

Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of Meridian Bioscience Inc. were yielding above the 4% mark based on its quarterly dividend (annualized to $0.80), with the stock changing hands as low as $19.85 on the day.

Meridian Bioscience Reports Fourth Quarter And Full-Year Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2016 Guidance

Meridian Bioscience Reports Fourth Quarter And Full-Year Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2016 Guidance

Meridian Bioscience, Inc. (NASDAQ: VIVO): GENERAL HIGHLIGHTS Meridian Bioscience, Inc.

RSI Alert: Meridian Bioscience Now Oversold

RSI Alert: Meridian Bioscience Now Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc.